InBios International
This role involves designing, building, and scaling point-of-care diagnostic assays from early development through manufacturing transfer within a wet-lab environment. The position focuses on enhancing assay sensitivity and performance through novel techniques while ensuring robust optimization and troubleshooting in a GMP setting. The scientist will work collaboratively to advance diagnostic solutions for emerging infectious diseases and biothreats.
InBios International is a Seattle-based, privately owned company founded in 1996 that designs, develops, and manufactures superior quality immunodiagnostic products for infectious diseases such as Dengue, West Nile, Zika, Chikungunya, COVID-19, and more. The company offers diagnostic tests, contract manufacturing, and assay development services, serving clinical labs globally. InBios is FDA registered, USDA licensed, and ISO 13485:2016 certified, with over 25 diagnostic products on the market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for InBios International.